Creo Medical Group PLC (AIM:CREO)
10.74
-0.15 (-1.33%)
Nov 6, 2026, 4:16 PM GMT
Creo Medical Group Revenue
Creo Medical Group had revenue of 2.20M GBP in the half year ending June 30, 2025, a decrease of -85.99%. This brings the company's total for the last twelve months to 4.60M, down -72.46% year-over-year. In the year 2024, Creo Medical Group had annual revenue of 4.00M. That makes Creo Medical Group the 37,661st largest company in the world by revenue and 734th in the United Kingdom.
Revenue (ttm)
4.60M
Revenue Growth
-72.46%
P/S Ratio
6.87
Revenue / Employee
67.31K
Employees
104
Market Cap
48.12M
Revenue by Geography
- United Kingdom 2.70M 45.0%
- Rest of World 2.70M 45.0%
- Europe 600.00K 10.0%
Fiscal year ended Dec 31, 2025 See the full Creo Medical Group breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.00M | - | - |
| Dec 31, 2023 | 4.00M | -23.20M | -85.29% |
| Dec 31, 2022 | 27.20M | 2.04M | 8.10% |
| Dec 31, 2021 | 25.16M | 15.73M | 166.85% |
| Dec 31, 2020 | 9.43M | 9.42M | 69,884.41% |
| Dec 31, 2019 | 13.47K | - | - |
| Jun 30, 2018 | - | - | - |
| Jun 30, 2017 | - | - | - |
| Feb 29, 2016 | - | - | - |
| Feb 28, 2015 | - | - | - |
| Feb 28, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Smith & Nephew | 4.77B |
| AOTI, Inc. | 52.74M |
| EKF Diagnostics Holdings | 51.35M |
| NIOX Group | 47.50M |
| Inspiration Healthcare Group | 45.60M |
| Surgical Innovations Group | 11.48M |
| RUA Life Sciences | 4.62M |
| Proteome Sciences | 3.77M |
Creo Medical Group News
- 5 weeks ago - Creo Records Lower H1 Loss Of £6 Mln; Full Year Revenue Growth Estimated At 50%-60% - Nasdaq